{"ticker": {"uuid": "ec4e7a16-0a60-48bc-93fd-895251b58cb0", "symbol": "000105", "name": "Yuhan Corporation", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Yuhan stock holds ground as earnings and pipeline shape valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPeDhMeEpkaHRnWTlHWWVhUGlleHdyczdxd20yOTZQVW9oM0ZHT3dSZXVJOG9nbjNWdjZGd1pjZGpmRGw4eWdpc1p0SGJVQjM3bWs2V0V1UlR3bnhlVmxNOTd5ZjZrYi1XN281Mmg3V1phQmUtT21nMzVSLVo4b1VPS1RGcUZ1Yjhael9iN0MyNXBKSlVJZG4xRy1wT0h4VVlrWVpiT0VDSEcxc2hkbUU5ZHV0andhSHlIY3ZFeVdjbFJzdw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T15:45:19+00:00", "published_display": "17 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Yuhan Corporation Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTFBtTGc3cGFMTGxNamxZWlJZZnhoUnVYczhyQldYNmVBUHA0b09iZ2paQjJaNHhVREtyVUNVUlg4dHNkTktXeE0xNmJ1THo1UHhCTjhJUFU3WHFzNTlYWnRpRHp3?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T04:46:01+00:00", "published_display": "12 Jul 2026 04:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan stock tracks its core pharma business", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOZ3dEbTNQYkF5cndKaERGa1dnS0tQbWdkc2FWNHc1bGp2SUhCNjJ4YlBOVjYyX2tYRk5pNHZyUDJob3dwcmFuc2U2WjJUcDFpbkp2RWkyc0JGUzJCU3RnN3JuOGx1OW5DZmtSM3hxd3VZak56QTdmakFGWVVzYjEwemZ4QUphaVN0OGktNVBtYlJsQW9JSzJnME1MZVlLcElZd2FmbQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan honors Yu Il-han, pioneer of Korea\u2019s employee ownership and philanthropy - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQdkoxWUpuRzBLSGhmSmdCNklLY0lVbDFqbVJBOFdCdTFXMjYwLUhvOTZEeXVWRElIaU52MG80OTQxczdxdGpmV0ExUU9uWnhtYVFzX1JuVlBkTG85WUdiaWsxdkJrc1luLWtqOU85aENkYUFQNXV4MGx1bUpla2hneNIBlAFBVV95cUxNTTBZX2MxRFEzczIyNk9heHJkZVFubWIxQnktcl9pbDZkRzgtaldWQlJXVkZyMzIwQTQzTnp6b0htZG9zREphQXdXb18xcDRwM1pDZVEwUWJLM21nNkp0MDBPVnBnSUJ1WGpNaDdzMGVlRWx5cUJSUVJYR1J3MXVIM05Sbkg0SmVFbXJ2S0tqeDBLR2wz?oc=5", "source_name": "Chosunbiz", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan hesitation over ImmuneOncia rights offering fuels Korea biotech backlash - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQbjhTTUdwS2lvZDIxWGE5cmdjN18ycUxpSDZjSng3OTE0cGRySFZQWUs4M1JPdG9fWURscjVHVXZaRlpMTk5tR2pLVlNPam52bGVlcWgwN3FSZjlUaV9QVGxxNXFYSUlmZjl5V0VmeDNmWmhnOUZSVGZlc2NQLTlCQtIBlAFBVV95cUxNZFFzVTMtaHFHcjBvY0s1dWh4dDNfUlp4WlpWaU5XOVhndkF0X0FPRVRpSVREbXZnS3RUdWpDUE91UVE0a0ZPYVhuOXV0M0h5T2NNVG1XRzIxX2RoOTM1MVA5elNHNmFOcm5ERnZMVlZOUUFUU0YyVkFxd0MtdHYxTXdlV1N6NWdidmc5akdOekZsLVNP?oc=5", "source_name": "Chosunbiz", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kimberly Clark, a global personal goods manufacturing company that is a major shareholder of Yuhan K..", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE5hS0pnLUZIS0RoQmxuMUFfTDV4R2dBSTFzWFJJMXRDVXlBRTFNV1lFbThGUnk5Ynl0aWVfV29oQVJoU2czQjVCbUVDQmZNbEE?oc=5", "source_name": "\ub9e4\uc77c\uacbd\uc81c", "published_at": "2025-08-13T07:00:00+00:00", "published_display": "13 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Global personal product manufacturer Kimberly-Clark, the majority shareholder of Yuhan Kimberly, is", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE1XMW5Gel9EUklaVTBtOVpZclZkN3Rqck1CUTR4bi1tNXJvUEF6WEhHZ2hvaEc3d1pzZWdJVTFPM0xIa0VWMDdESldTa2U1LTQ?oc=5", "source_name": "\ub9e4\uc77c\uacbd\uc81c", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan\u2019s biotech arm ImmuneOncia soars 108% in IPO on rare cancer strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1UbkJ5UTVVZTdKU1Q4RWp5Uk05T0oxWkhhLXRoYnJ5YzJzYUxoUnZfaHA0SldqRXZxdHhuRndPRmV6U2JKbGU4NVNxZ25hQlhVTjJVNi1pQXFwd2lXVEhmODZrSjZld2RsaGV4Vm9R0gFyQVVfeXFMTzNncmdoSkUxblFyc2d3YzVmWlFtNEV3YUNLWW95OWU1YjY0UlBrZ01iYWR1M1VDcWhoQW1sUTNvMUh3aXNYWW5TUkIzekdvV0QtNTFLMkVoeFp1T1hRQVhXZjBuZk9SaTkyX3dyTlRIZ1dB?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-05-19T07:00:00+00:00", "published_display": "19 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MASH field still hot as Boehringer axes $870M deal with Yuhan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzE5VHptbEVTRk9FOGpEWGh3M0hEM3BVbDhHd3NkOEMtU3RtNW9PcE1nbHZiQ1dSUno5cTRabXlkcUxNYUR4dDNvcGJVMi1vNlhaTE9WZ3NtcnVmOXp4SFdsVTN5aWZvQXlseVZ0blZJSlFCdXlMQzMtMnFLc2ltd09oWDMxb0gtZFBNRU9ER1pPYXlnZTFSUXNRWTVMV3EtbUlj?oc=5", "source_name": "BioWorld News", "published_at": "2025-03-11T07:00:00+00:00", "published_display": "11 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan sets ambitious targets for annual licensing deals, 30% shareholder return by 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBGd1NONUVTVTQ5eWdhd1d5a3lhVjhzVksxd0dpa3pubkNKaW1TQXFHY08wd08zSUtURzgzUVNoRGN4aVhIT3RMWndIaV8yYUVXN19oN3Z2djhuSHhjZV9VYm5PYXdMODFZUEg3dkJn0gFyQVVfeXFMTTZDeENWQS1STVBKUkZ1bDRLZUlIU013RU9sZkJzeGU0d2pwMnhCUnBkWGQ4NXB5NUhXeWhVaFBrcWhQZ0JXc0RkZWRadjl6VXhMVXhSSmVaZjEybTcxTDlDaFN1YXBWUmlXc2RfUHZOTlpR?oc=5", "source_name": "koreabiomed.com", "published_at": "2024-10-31T07:00:00+00:00", "published_display": "31 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "South Korea\u2019s Yuhan has 690% profit spike on U.S. lung cancer drug sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPVDNBNnFXcVA5NXZxakJyU2kxT1Z2YndIb1hWZ2dIbFVtazdBczhKZHZvTkVOSGVoajFWSnFiYUhveFpLZmlIX0VZY00xMjNOZDQtTnYxTEZjMkIzdUFZTkJLTGNQOUpSSGNQQXFFT1RPYkRSMVN5S1d1bzJtOGxsUzM3YmpWYTZKaF9yMXV2aWg1SEl5ZUI1dw?oc=5", "source_name": "Mugglehead Investment Magazine", "published_at": "2024-10-28T07:00:00+00:00", "published_display": "28 Oct 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead taps Korea's Yuhan to supply HIV drug ingredients in $81M deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPZ1NtcUZldHpkTzFoZGdrcHlnTGI4MHFGNzhtbmZvVFpZMnFYMkdGaHFpMFBheHNkU0p2T0ZRNTFJeDZfc29qMmxoNWdiUDMzRjZjMnA4RlZVNHIwTmJ0enN0WEFTQ2dfTTdlTC1WcnJvc2J6dG9GLUhwU0dRbHJNWF9tVF9nS1JnNVMwcWktdnlPdw?oc=5", "source_name": "Fierce Pharma", "published_at": "2024-09-20T07:00:00+00:00", "published_display": "20 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan's Leclaza becomes 1st Korean-made anti-cancer drug to score FDA nod", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9qN253UGRyZ3dlSTZRUUZnYkhvVVRxX2JNQjZDVEtZbTRIQXRjZEdUX3Y2ai1DOGZ5ZHFNYjg4MHAwMTh6dFR5T1lhamxmZUdMWEtTbmV1VU1DR2lRcDh4QXpGNUpTNTNCa3hEOTJR0gFyQVVfeXFMTmp2cG1KWXlGM3ctdjZNYmxDRkVsTWJ3SHVEN2dDOHpwQ0pkcDBzQW9oT3FhdTVMWWtUTklRM0JVa2ZOVmpVQWlLR3F3cHhLUHAxNGdpOW92bHBzQV9oS0s1OER6d29JVGh2cGg1UEs3N2t3?oc=5", "source_name": "koreabiomed.com", "published_at": "2024-08-21T07:00:00+00:00", "published_display": "21 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Yuhan stock holds ground as earnings and pipeline shape valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPeDhMeEpkaHRnWTlHWWVhUGlleHdyczdxd20yOTZQVW9oM0ZHT3dSZXVJOG9nbjNWdjZGd1pjZGpmRGw4eWdpc1p0SGJVQjM3bWs2V0V1UlR3bnhlVmxNOTd5ZjZrYi1XN281Mmg3V1phQmUtT21nMzVSLVo4b1VPS1RGcUZ1Yjhael9iN0MyNXBKSlVJZG4xRy1wT0h4VVlrWVpiT0VDSEcxc2hkbUU5ZHV0andhSHlIY3ZFeVdjbFJzdw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T15:45:19+00:00", "published_display": "17 Jul 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Yuhan Corporation Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTFBtTGc3cGFMTGxNamxZWlJZZnhoUnVYczhyQldYNmVBUHA0b09iZ2paQjJaNHhVREtyVUNVUlg4dHNkTktXeE0xNmJ1THo1UHhCTjhJUFU3WHFzNTlYWnRpRHp3?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T04:46:01+00:00", "published_display": "12 Jul 2026 04:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan stock tracks its core pharma business", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOZ3dEbTNQYkF5cndKaERGa1dnS0tQbWdkc2FWNHc1bGp2SUhCNjJ4YlBOVjYyX2tYRk5pNHZyUDJob3dwcmFuc2U2WjJUcDFpbkp2RWkyc0JGUzJCU3RnN3JuOGx1OW5DZmtSM3hxd3VZak56QTdmakFGWVVzYjEwemZ4QUphaVN0OGktNVBtYlJsQW9JSzJnME1MZVlLcElZd2FmbQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan honors Yu Il-han, pioneer of Korea\u2019s employee ownership and philanthropy - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQdkoxWUpuRzBLSGhmSmdCNklLY0lVbDFqbVJBOFdCdTFXMjYwLUhvOTZEeXVWRElIaU52MG80OTQxczdxdGpmV0ExUU9uWnhtYVFzX1JuVlBkTG85WUdiaWsxdkJrc1luLWtqOU85aENkYUFQNXV4MGx1bUpla2hneNIBlAFBVV95cUxNTTBZX2MxRFEzczIyNk9heHJkZVFubWIxQnktcl9pbDZkRzgtaldWQlJXVkZyMzIwQTQzTnp6b0htZG9zREphQXdXb18xcDRwM1pDZVEwUWJLM21nNkp0MDBPVnBnSUJ1WGpNaDdzMGVlRWx5cUJSUVJYR1J3MXVIM05Sbkg0SmVFbXJ2S0tqeDBLR2wz?oc=5", "source_name": "Chosunbiz", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan hesitation over ImmuneOncia rights offering fuels Korea biotech backlash - CHOSUNBIZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQbjhTTUdwS2lvZDIxWGE5cmdjN18ycUxpSDZjSng3OTE0cGRySFZQWUs4M1JPdG9fWURscjVHVXZaRlpMTk5tR2pLVlNPam52bGVlcWgwN3FSZjlUaV9QVGxxNXFYSUlmZjl5V0VmeDNmWmhnOUZSVGZlc2NQLTlCQtIBlAFBVV95cUxNZFFzVTMtaHFHcjBvY0s1dWh4dDNfUlp4WlpWaU5XOVhndkF0X0FPRVRpSVREbXZnS3RUdWpDUE91UVE0a0ZPYVhuOXV0M0h5T2NNVG1XRzIxX2RoOTM1MVA5elNHNmFOcm5ERnZMVlZOUUFUU0YyVkFxd0MtdHYxTXdlV1N6NWdidmc5akdOekZsLVNP?oc=5", "source_name": "Chosunbiz", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kimberly Clark, a global personal goods manufacturing company that is a major shareholder of Yuhan K..", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE5hS0pnLUZIS0RoQmxuMUFfTDV4R2dBSTFzWFJJMXRDVXlBRTFNV1lFbThGUnk5Ynl0aWVfV29oQVJoU2czQjVCbUVDQmZNbEE?oc=5", "source_name": "\ub9e4\uc77c\uacbd\uc81c", "published_at": "2025-08-13T07:00:00+00:00", "published_display": "13 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Global personal product manufacturer Kimberly-Clark, the majority shareholder of Yuhan Kimberly, is", "summary": "", "url": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE1XMW5Gel9EUklaVTBtOVpZclZkN3Rqck1CUTR4bi1tNXJvUEF6WEhHZ2hvaEc3d1pzZWdJVTFPM0xIa0VWMDdESldTa2U1LTQ?oc=5", "source_name": "\ub9e4\uc77c\uacbd\uc81c", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan\u2019s biotech arm ImmuneOncia soars 108% in IPO on rare cancer strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1UbkJ5UTVVZTdKU1Q4RWp5Uk05T0oxWkhhLXRoYnJ5YzJzYUxoUnZfaHA0SldqRXZxdHhuRndPRmV6U2JKbGU4NVNxZ25hQlhVTjJVNi1pQXFwd2lXVEhmODZrSjZld2RsaGV4Vm9R0gFyQVVfeXFMTzNncmdoSkUxblFyc2d3YzVmWlFtNEV3YUNLWW95OWU1YjY0UlBrZ01iYWR1M1VDcWhoQW1sUTNvMUh3aXNYWW5TUkIzekdvV0QtNTFLMkVoeFp1T1hRQVhXZjBuZk9SaTkyX3dyTlRIZ1dB?oc=5", "source_name": "koreabiomed.com", "published_at": "2025-05-19T07:00:00+00:00", "published_display": "19 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MASH field still hot as Boehringer axes $870M deal with Yuhan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzE5VHptbEVTRk9FOGpEWGh3M0hEM3BVbDhHd3NkOEMtU3RtNW9PcE1nbHZiQ1dSUno5cTRabXlkcUxNYUR4dDNvcGJVMi1vNlhaTE9WZ3NtcnVmOXp4SFdsVTN5aWZvQXlseVZ0blZJSlFCdXlMQzMtMnFLc2ltd09oWDMxb0gtZFBNRU9ER1pPYXlnZTFSUXNRWTVMV3EtbUlj?oc=5", "source_name": "BioWorld News", "published_at": "2025-03-11T07:00:00+00:00", "published_display": "11 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan sets ambitious targets for annual licensing deals, 30% shareholder return by 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBGd1NONUVTVTQ5eWdhd1d5a3lhVjhzVksxd0dpa3pubkNKaW1TQXFHY08wd08zSUtURzgzUVNoRGN4aVhIT3RMWndIaV8yYUVXN19oN3Z2djhuSHhjZV9VYm5PYXdMODFZUEg3dkJn0gFyQVVfeXFMTTZDeENWQS1STVBKUkZ1bDRLZUlIU013RU9sZkJzeGU0d2pwMnhCUnBkWGQ4NXB5NUhXeWhVaFBrcWhQZ0JXc0RkZWRadjl6VXhMVXhSSmVaZjEybTcxTDlDaFN1YXBWUmlXc2RfUHZOTlpR?oc=5", "source_name": "koreabiomed.com", "published_at": "2024-10-31T07:00:00+00:00", "published_display": "31 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "South Korea\u2019s Yuhan has 690% profit spike on U.S. lung cancer drug sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPVDNBNnFXcVA5NXZxakJyU2kxT1Z2YndIb1hWZ2dIbFVtazdBczhKZHZvTkVOSGVoajFWSnFiYUhveFpLZmlIX0VZY00xMjNOZDQtTnYxTEZjMkIzdUFZTkJLTGNQOUpSSGNQQXFFT1RPYkRSMVN5S1d1bzJtOGxsUzM3YmpWYTZKaF9yMXV2aWg1SEl5ZUI1dw?oc=5", "source_name": "Mugglehead Investment Magazine", "published_at": "2024-10-28T07:00:00+00:00", "published_display": "28 Oct 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead taps Korea's Yuhan to supply HIV drug ingredients in $81M deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPZ1NtcUZldHpkTzFoZGdrcHlnTGI4MHFGNzhtbmZvVFpZMnFYMkdGaHFpMFBheHNkU0p2T0ZRNTFJeDZfc29qMmxoNWdiUDMzRjZjMnA4RlZVNHIwTmJ0enN0WEFTQ2dfTTdlTC1WcnJvc2J6dG9GLUhwU0dRbHJNWF9tVF9nS1JnNVMwcWktdnlPdw?oc=5", "source_name": "Fierce Pharma", "published_at": "2024-09-20T07:00:00+00:00", "published_display": "20 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuhan's Leclaza becomes 1st Korean-made anti-cancer drug to score FDA nod", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE9qN253UGRyZ3dlSTZRUUZnYkhvVVRxX2JNQjZDVEtZbTRIQXRjZEdUX3Y2ai1DOGZ5ZHFNYjg4MHAwMTh6dFR5T1lhamxmZUdMWEtTbmV1VU1DR2lRcDh4QXpGNUpTNTNCa3hEOTJR0gFyQVVfeXFMTmp2cG1KWXlGM3ctdjZNYmxDRkVsTWJ3SHVEN2dDOHpwQ0pkcDBzQW9oT3FhdTVMWWtUTklRM0JVa2ZOVmpVQWlLR3F3cHhLUHAxNGdpOW92bHBzQV9oS0s1OER6d29JVGh2cGg1UEs3N2t3?oc=5", "source_name": "koreabiomed.com", "published_at": "2024-08-21T07:00:00+00:00", "published_display": "21 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 55, "total_relevant": 13, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 12, "score": 51, "total": 13, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 58200.0, "latest_week": "2026-07-10", "one_week_move": -3.0, "four_week_move": -9.1, "twelve_week_move": -31.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.494246, "market_dynamics_buy_signal": false, "relative_strength": -62.576189, "fair_value_gap": -33.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.723, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.0% over one week, -9.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "koreabiomed.com", "count": 3}, {"label": "ad-hoc-news.de", "count": 2}, {"label": "Chosunbiz", "count": 2}, {"label": "\ub9e4\uc77c\uacbd\uc81c", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "Mugglehead Investment Magazine", "count": 1}, {"label": "Fierce Pharma", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 13}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "13", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.0% over one week, -9.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Yuhan stock holds ground as earnings and pipeline shape valuation"}], "updated_at": "2026-07-17T22:39:49.914303+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}